Our results strongly indicate that current smoking is a major contributing factor to increased MPO and MMP-9 levels in patients with CAD regardless of OSA, which may partly explain the lack of significant differences in major adverse outcomes in OSA versus no-OSA in the ISAACC trial. This evidence concerns the gene MMP9 and coronary artery disorder.